SILVER SPRING, Md., Sept. 13, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen (a substance that could cause ca

PALM BEACH, Florida, Sept. 13, 2019 /PRNewswire/ -- This October, CBD will retake center stage.  In fact, on October 17, 2019, Canada is expected to legalize it for the second time.  A year after Canada legalized dried cannabis flower, oils, and sprays, the country i

NORTH MIAMI BEACH, Fla., Sept. 13, 2019 /PRNewswire/ -- September is National Childhood Cancer Awareness Month and the Forces are showing up Gold EVERYWHERE!  Join Mystic Force for the 2nd Annual Childhood Cancer Awareness Police Car Initiative showcasing Police Vehicles from all the departments in Miami Dade County

THOUSAND OAKS, Calif., Sept. 13, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 CANDOR study evaluating KYPROLIS® (carfilzomib) in combination with dexamethasone and DARZALEX® (daratumumab) (KdD) compared to KYPROLIS and dexamethasone alone (Kd) met its primary endpoint of progression-free survival (PFS). The regim

NEUCHATEL, Switzerland, Sept. 13, 2019 /PRNewswire/ -- MBP Solutions, the pioneering and world-leading provider of biological by-product outsourcing services (OMBP), today celebrates its 20th anniversary in business and revealed its new, updated corporate identity - developed to support the continuing growth of the business based on turning one ind

SUWANEE, Ga., Sept. 13, 2019 /PRNewswire/ -- Xstrahl, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its full range of superficial/orthovoltage treatments systems and radiation research platforms at ASTRO 2019.  Xstrahl is introducing image guidance capabilities for its range

PALO ALTO, Calif. and PHILADELPHIA, Sept. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a privately-held digital health company using software and data to equip d

STOCKHOLM, Sept. 13, 2019 /PRNewswire/ -- IRRAS AB, a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that Vinny Podichetty VP, Clinical, Regulatory Affairs & Quality has resigned for personal reasons, and two key appointments to drive IRRAS' continued growth. Niloufa Ins

AVONDALE, Pa., Sept. 13, 2019 /PRNewswire/ -- Qfix MRimage and Treat positioning products offer solutions that enable patients to benefit from MR, CT and treatment - all using the same device. Use of magnetic resonance imaging in radiotherapy planning has rapidly increased due to its superior soft tissue visualization. Qfix MRimage & Treat device

WOODCLIFF LAKE, N.J., Sept. 13, 2019 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Michel Vounatsos, "Biogen") today announc